Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial
暂无分享,去创建一个
R. Greil | M. Gnant | P. Dubsky | R. Exner | R. Jakesz | F. Fitzal | P. Sevelda | C. Singer | G. Steger | M. Balic | H. Stöger | B. Mlineritsch | D. Egle | J. Thaler | C. Tausch | V. Bjelic-Radisic | F. Haslbauer | R. Helfgott | L. Sölkner | V. Wette | E. Melbinger-Zeinitzer | M. Moik | U. Selim | D. Manfreda | H. Trapl | M. Balić | H. Stöger